• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危和低危人群中前列腺癌患者的血液激素谱。

Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations.

作者信息

Ahluwalia B, Jackson M A, Jones G W, Williams A O, Rao M S, Rajguru S

出版信息

Cancer. 1981 Nov 15;48(10):2267-73. doi: 10.1002/1097-0142(19811115)48:10<2267::aid-cncr2820481023>3.0.co;2-r.

DOI:10.1002/1097-0142(19811115)48:10<2267::aid-cncr2820481023>3.0.co;2-r
PMID:7296478
Abstract

Epidemiologic data reveal that the incidence rate of prostate gland carcinoma among the black population in the United States (US) is several times higher than among Nigerians. A collaborative study between the two countries was undertaken, and blood hormone (testosterone [T], dihydrotestosterone [DHT], estrone [E1], estradiol [E2], and prolactin [P1]), total acid phosphatase (TP), and prostatic acid phosphatase (PAP) profiles in the two population groups were compared. In the US groups (patients and controls) there were significantly higher levels of T (P less than 0.01) and E1 (P less than 0.05) compared with the Nigerians. Also, the US patients had significantly higher levels of T (P less than 0.05) and E1 (P less than 0.01) compared with their matched controls. In the Nigerians T but not E1 levels were significantly lower (P less than 0.05) in patients compared with controls. DHT, E2, and P1 were not significantly different in patients and controls between and within the populations. Nigerian patients had higher levels (P less than 0.001) of TP and PAP compared with US patients. It is concluded that differences in blood hormone profiles in the two population groups are based on factors other than the genetic makeup of the populations.

摘要

流行病学数据显示,美国黑人人群中前列腺癌的发病率比尼日利亚人高出数倍。两国开展了一项合作研究,比较了这两个人群组的血液激素(睾酮 [T]、双氢睾酮 [DHT]、雌酮 [E1]、雌二醇 [E2] 和催乳素 [P1])、总酸性磷酸酶(TP)和前列腺酸性磷酸酶(PAP)水平。与尼日利亚人相比,美国组(患者和对照组)的T(P<0.01)和E1(P<0.05)水平显著更高。此外,与匹配的对照组相比,美国患者的T(P<0.05)和E1(P<0.01)水平显著更高。在尼日利亚人中,与对照组相比,患者的T水平显著较低(P<0.05),但E1水平无显著差异。人群之间和人群内部的患者与对照组中,DHT、E2和P1无显著差异。与美国患者相比,尼日利亚患者的TP和PAP水平更高(P<0.001)。得出的结论是,两个人群组血液激素水平的差异是基于人群基因组成以外的因素。

相似文献

1
Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations.高危和低危人群中前列腺癌患者的血液激素谱。
Cancer. 1981 Nov 15;48(10):2267-73. doi: 10.1002/1097-0142(19811115)48:10<2267::aid-cncr2820481023>3.0.co;2-r.
2
Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC.黑人前列腺癌的特征:尼日利亚伊巴丹低发病率地区与华盛顿特区高发病率地区的比较。
Prostate. 1980;1(2):185-205. doi: 10.1002/pros.2990010205.
3
Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.良性前列腺增生症和前列腺癌中的血浆类固醇
J Steroid Biochem. 1982 Dec;17(6):689-93. doi: 10.1016/0022-4731(82)90572-6.
4
Abnormal levels of plasma hormones in men with prostate cancer: evidence toward a "two-disease" theory.
Prostate. 1982;3(6):579-88. doi: 10.1002/pros.2990030607.
5
Characterization of prostatic carcinoma among blacks: a preliminary report.黑人前列腺癌的特征:初步报告。
Cancer Chemother Rep. 1975 Jan-Feb;59(1):3-15.
6
Characterization of prostatic carcinoma among blacks: a continuation report.黑人前列腺癌的特征:一份续报。
Cancer Treat Rep. 1977 Mar-Apr;61(2):167-72.
7
Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.癌症的血清学先兆:血清激素与后续前列腺癌风险
Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):27-32.
8
[Interdependence between hormonal disorders, stage of development and degree of malignancy of prostatic cancer. 1].[激素紊乱、发育阶段与前列腺癌恶性程度之间的相互依存关系。1]
J Urol (Paris). 1983;89(8):597-600.
9
Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.美国和加拿大老年非裔美国人、白人和亚洲男性血清雄激素和性激素结合球蛋白与生活方式因素的关系。
Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):735-41.
10
Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法检测月经周期和绝经后妇女的睾酮、二氢睾酮、雌二醇和雌酮水平。
Steroids. 2011 Jan;76(1-2):177-82. doi: 10.1016/j.steroids.2010.10.010. Epub 2010 Nov 9.

引用本文的文献

1
Associating serum testosterone levels with African ancestral prostate cancer health disparities.将血清睾酮水平与非洲裔前列腺癌健康差异联系起来。
Sci Rep. 2025 Apr 8;15(1):12013. doi: 10.1038/s41598-025-92539-y.
2
The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens.雌激素在前列腺癌中的利弊:聚焦植物雌激素的最新进展
Biomedicines. 2024 Jul 23;12(8):1636. doi: 10.3390/biomedicines12081636.
3
Testosterone replacement in prostate cancer survivors with testosterone deficiency: Study protocol of a randomized controlled trial.
雄激素缺乏的前列腺癌幸存者的雄激素替代治疗:一项随机对照试验的研究方案。
Andrology. 2023 Jan;11(1):93-102. doi: 10.1111/andr.13299. Epub 2022 Oct 13.
4
The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy.下丘脑-垂体-性腺轴与前列腺癌:对雄激素剥夺治疗的影响
World J Urol. 2014 Jun;32(3):669-76. doi: 10.1007/s00345-013-1157-5. Epub 2013 Sep 3.
5
Do evolutionary life-history trade-offs influence prostate cancer risk? a review of population variation in testosterone levels and prostate cancer disparities.进化的生活史权衡是否会影响前列腺癌的风险?睾酮水平的人群变异与前列腺癌差异的综述。
Evol Appl. 2013 Jan;6(1):117-33. doi: 10.1111/eva.12036. Epub 2012 Dec 11.
6
The precise role of ethnicity and family history on aggressive prostate cancer: a review analysis.种族和家族史在侵袭性前列腺癌中的精确作用:一项综述分析
Arch Esp Urol. 2011 Oct;64(8):711-9.
7
Cardiorespiratory fitness and risk of prostate cancer: findings from the Aerobics Center Longitudinal Study.心肺适能与前列腺癌风险:来自有氧运动中心纵向研究的结果。
Cancer Epidemiol. 2011 Feb;35(1):59-65. doi: 10.1016/j.canep.2010.07.013. Epub 2010 Aug 13.
8
Androgen supplementation and prostate cancer risk: strategies for pretherapy assessment and monitoring.雄激素补充与前列腺癌风险:治疗前评估与监测策略
Rev Urol. 2003;5 Suppl 1(Suppl 1):S29-33.
9
Challenges with luteinizing hormone-releasing hormone agonists: flare and surge.促黄体生成素释放激素激动剂的挑战:激发和激增。
Rev Urol. 2004;6 Suppl 7(Suppl 7):S12-8.
10
Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy.睾酮:其在前列腺癌发生中的作用以及用作激素替代疗法的潜在风险。
Drugs Aging. 2000 Dec;17(6):431-9. doi: 10.2165/00002512-200017060-00001.